Delivery Order SPE2DB24D3013-SPE2DB25FFQYN
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,553.26, with an ultimate completion date of July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,185.22 by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Trulicity 3 mg/0.5 ml pen injectable medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation and performance location in Conshohocken, Pennsylvania. The delivery order is scheduled for completion by September 11, 2025. This award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $5,405.40 by the Defense Logistics Agency on September 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract carries a firm fixed price structure with an ultimate completion date of September 12, 2025, and utilizes no set-aside designation. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,500.88 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,858.72. This competitive award, issued without a set-aside designation, carries a firm fixed price structure with an ultimate completion date of July 24, 2025. The product will be performed and distributed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 26, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 3 mg/0.5 mL pens with a ceiling value of $6,006.00. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025. The contract is not set-aside and represents a competitive award under the company's existing indefinite delivery contract vehicle with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 26, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens valued at $6,006.00, with an ultimate completion date of September 29, 2025. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,302.84 for Trulicity 1.5 mg/0.5 ml pens by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025. This firm fixed-price contract is not set-aside and represents a single delivery of the diabetes medication to support military healthcare operations. The award is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQYNDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,109.08 by the Defense Logistics Agency on September 25, 2025, for the supply of Trulicity 3 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with a completion date of September 26, 2025, and performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's larger pharmaceutical supply relationship with the federal government, serving military and veteran healthcare systems. This award is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver a diverse portfolio of medications and medical supplies across multiple therapeutic domains to support Department of Defense healthcare programs worldwide. AmerisourceBergen's competitive standing in federal pharmaceutical procurement is evidenced by its consistent receipt of non-set-aside awards across a wide range of medical products, demonstrating the company's capability to meet stringent federal medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 9/25/25 |